Cargando…
电离辐射降低NSCLC细胞株T790M突变所致TKI耐药
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), which targets EGFR, plays an important role in non-small cell lung cancer (NSCLC) treatment. Patients with somatic activating mutations in the EGFR gene exhibit significant initial response but eventuall...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000229/ https://www.ncbi.nlm.nih.gov/pubmed/26302343 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.02 |